Treatment of Malaria With Quinine Plus Sulfadoxine-Pyrimethamine
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
Quinine remains the treatment of choice of hospitalised malaria cases. The long treatment
duration of 7 days, and adverse reactions often hamper its adequate use. Reducing the
treatment duration by adding sulfadoxine-pyrimethamine may enhance compliance and reduce side
effects.
The efficacy of a 3-day treatment of quinine plus sulfadoxine-pyrimethamine for the treatment
of hospitalised, uncomplicated malaria cases was assessed.
Phase:
Phase 4
Details
Lead Sponsor:
Albert Schweitzer Hospital
Treatments:
Fanasil, pyrimethamine drug combination Pyrimethamine Quinine Sulfadoxine